Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
L. Patrick Gage currently holds 28,932 shares of PDL BIOPHARMA, INC. (PDLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, L. Patrick Gage has been a net seller of PDLI stock. They have purchased $490.4K and sold $2.7M worth of shares.
L. Patrick Gage's most recent insider trade was on Nov 8, 2021, when they sold 4,166 shares at $41.33 per share.
L. Patrick Gage serves as Executive at PDL BIOPHARMA, INC. (PDLI). They have executed 76 insider transactions totaling $3.2M over their tenure at the company.
L. Patrick Gage holds the position of Executive at PDL BIOPHARMA, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
L. Patrick Gage has shown a selling trading pattern, with $490.4K in total purchases and $2.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by L. Patrick Gage was on Nov 8, 2021, when they sold $921.7K worth of CYTK shares. This transaction involved 22,302 shares at $41.33 per share.
L. Patrick Gage currently owns 28,932 shares of PDL BIOPHARMA, INC. (PDLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of L. Patrick Gage's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. L. Patrick Gage has 76 Form 4 filings on record as an insider at PDL BIOPHARMA, INC..
Set alerts for L. Patrick Gage and 40,000+ other insiders.